ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2016

Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy.

Kanerva Lahdensuo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.